IDEAYA Biosciences Statistics
Total Valuation
IDYA has a market cap or net worth of $2.53 billion. The enterprise value is $1.58 billion.
Important Dates
The last earnings date was Monday, November 4, 2024, before market open.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
IDYA has 84.48 million shares outstanding. The number of shares has increased by 43.06% in one year.
Shares Outstanding | 84.48M |
Shares Change (YoY) | +43.06% |
Shares Change (QoQ) | +10.55% |
Owned by Insiders (%) | 1.06% |
Owned by Institutions (%) | 100.78% |
Float | 83.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.45 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 403.77 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -19.46% |
Revenue Per Employee | $31,629 |
Profits Per Employee | -$1.44M |
Employee Count | 124 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.59% in the last 52 weeks. The beta is 0.86, so IDYA's price volatility has been lower than the market average.
Beta (5Y) | 0.86 |
52-Week Price Change | +3.59% |
50-Day Moving Average | 32.96 |
200-Day Moving Average | 39.04 |
Relative Strength Index (RSI) | 46.35 |
Average Volume (20 Days) | 724,792 |
Short Selling Information
The latest short interest is 9.61 million, so 11.37% of the outstanding shares have been sold short.
Short Interest | 9.61M |
Short Previous Month | 12.08M |
Short % of Shares Out | 11.37% |
Short % of Float | 11.49% |
Short Ratio (days to cover) | 10.01 |
Income Statement
In the last 12 months, IDYA had revenue of $3.92 million and -$178.12 million in losses. Loss per share was -$2.34.
Revenue | 3.92M |
Gross Profit | -125.59M |
Operating Income | -224.75M |
Pretax Income | -153.74M |
Net Income | -178.12M |
EBITDA | -222.26M |
EBIT | -224.75M |
Loss Per Share | -$2.34 |
Full Income Statement Balance Sheet
The company has $701.66 million in cash and $1.87 million in debt, giving a net cash position of $950.86 million or $11.26 per share.
Cash & Cash Equivalents | 701.66M |
Total Debt | 1.87M |
Net Cash | 950.86M |
Net Cash Per Share | $11.26 |
Equity (Book Value) | 931.66M |
Book Value Per Share | 12.24 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -5,730.60% |
Pretax Margin | -4,541.56% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,123.38% |